全球避孕器具市场（2023-2030）：按产品和最终用户分類的规模、份额、成长分析和预测

全球避孕器具市场规模将从2021年的266.8亿美元成长到2022年的283亿美元，预测期内年复合成长率为6.06%，预计到2030年将达到453.1亿美元。

避孕技术的突破包括高效非荷尔蒙子宫内避孕器 (IUD) 的开发。这种创新装置为女性提供了可靠、持久的避孕方法。这款子宫内避孕器具有独特的设计，可提高安全性和易用性，最大限度地减少潜在的副作用，使其成为无忧的避孕解决方案。它的有效性和易用性使其成为寻求方便可靠的避孕方法的女性的一个有前途的选择。

该市场也受到许多其他因素的推动，例如意外怀孕率上升、对计划生育技术的了解和使用的增加。此外，性传染感染的激增和政府对计划生育计画的资助增加也推动了市场的成长。许多避孕方法的出现，包括保险套、避孕器、口服避孕药和皮下埋植剂，以及消费者食慾的增加，也有助于市场的扩张。此外，电子商务行业的兴起、长效可逆避孕药的开发以及产品创新也正在推动市场。同时，对非荷尔蒙避孕药和天然避孕药的需求不断增长，以及女性主导的避孕技术的日益普及，两者都在推动市场扩张。

本报告调查了全球避孕器具市场，并提供了市场概况、市场各种影响因素分析、技术和创新趋势、法律制度、市场规模趋势和预测，以及按不同细分市场和地区进行的细分。总结了主要企业的细分、竞争形势和概况。

目录

• 执行摘要
• 调查方法
• 母市场分析
  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
• 关键市场洞察
  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 重点投资分析
  • 关键成功因素
  • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
  • 法规状况
  • 波特的分析
  • Skyquest 对未来颠覆的独家见解
• 全球避孕器具市场：依产品
  • 市场概况
  • 保险套
  • 皮下植入物
  • 避孕药
  • 避孕环
  • 隔膜
• 全球避孕器具市场：依最终用户分类
  • 市场概况
  • 男性
  • 女士
• 全球避孕器具市场：依地区
  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲
• 竞争形势
  • 前5名企业对比
  • 主要企业市场地位
  • 主要企业的招募策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率
• 主要企业简介
  • Bayer AG
  • Pfizer Inc.
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Merck Sharp & Dohme Corp.
  • Mylan NV
  • Reckitt Benckiser Group plc.
  • Veru Inc.
  • Medisafe Distribution Inc.
  • CooperSurgical, Inc.
  • Devex
  • Mayer Laboratories, Inc.
  • Allergan plc
  • Agile Therapeutics
  • HLL Lifecare
  • ANSELL LTD
  • Mankind Pharma
  • TTK HealthCare
  • Boehringer Ingelheim International GmbH
  • V-Care Pharma Pvt. Ltd.

Global Contraceptive Devices Market size was valued at USD 26.68 billion in 2021 and is poised to grow from USD 28.3 billion in 2022 to USD 45.31 billion by 2030, growing at a CAGR of 6.06% during the forecast period (2023-2030).

To foster market growth, programs focused on reducing unintended pregnancies and associated healthcare costs and enhancing user awareness are anticipated. Numerous initiatives, such as Every Woman Every Child, Millennium Development Goals, the 2030 Sustainable Development Goals (SDGs), and Family Planning, have been launched by governments and healthcare organizations to promote family planning and the manufacturing and utilization of contraceptives. Private and public sectors both play significant roles as providers of contraceptives. The private sector primarily supplies short-acting resupply contraceptive methods like condoms and contraceptive pills, consistently holding a considerable market share. In Asia, for instance, around 41% of females obtain contraceptives from private-sector sources, while approximately 56% rely on public sources. Across 36 evaluated countries categorized as low- and middle-income, about 63% of women acquire contraceptives from the private sector, whereas approximately 34% utilize public-sector sources.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Contraceptive Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contraceptive Devices Market Segmental Analysis

Global Contraceptive Devices Market is segmented by product, end user, and region. Based on Product, the market can be segmented into condoms, subdermal implants, contraceptive drugs, vaginal rings, and diaphragms. Based on End user, the market is segmented into male and female. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Contraceptive Devices Market Dynamics

Drivers of the Global Contraceptive Devices Market

Development of a highly efficient

One groundbreaking advancement in contraceptive technology is the development of a highly efficient, non-hormonal intrauterine device (IUD). This innovative device offers women a reliable and long-lasting method of birth control. By utilizing a unique design that promotes both safety and ease of use, this IUD provides a hassle-free contraceptive solution while minimizing potential side effects. It's effectiveness and user-friendly nature make it a promising option for women seeking convenient and reliable contraception.

Restraints in the Global Contraceptive Devices

Market

Increasing risk of infections regarding the use of contraceptive devices

Contraceptive devices empower individuals to make informed choices about their reproductive health. By providing a reliable and accessible method of birth control, these devices promote reproductive autonomy and enable individuals to plan their families according to their personal circumstances. With a wide range of options available, including condoms, intrauterine devices (IUDs), and hormonal implants, contraceptive devices offer diverse choices to suit individual needs, fostering responsible sexual practices and reducing the risk of unintended pregnancies. Their availability promotes safer and healthier sexual experiences, ultimately empowering individuals to control their own reproductive journeys.

Market Trends of the Global Contraceptive Devices Key

The market is being driven by a number of factors, such as rising unwanted pregnancy rates and increased understanding and use of family planning techniques. Additionally, the soaring prevalence of STIs and the increased government financing for family planning programmes are promoting market expansion. The availability of numerous contraceptive methods, such as condoms, intrauterine devices, oral contraceptives, and subdermal implants, as well as rising consumer spending power, are also contributing to the market's expansion. In addition, the rise of the e-commerce industry, the development of long-acting reversible contraceptives, and the escalating trend of product innovations are boosting the market. This is in accordance with the growing demand for non-hormonal and natural contraceptives and the rising popularity of female-controlled contraceptive techniques, both of which are fostering market expansion.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Contraceptive Devices Market by Product
  • Market Overview
  • Condoms
  • Subdermal Implants
  • Contraceptive Drugs
  • Vaginal Rings
  • and Diaphragms
• Global Contraceptive Devices Market by End user
  • Market Overview
  • Male and Female
• Global Contraceptive Devices Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Bayer AG (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pfizer Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Janssen Global Services, LLC (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Teva Pharmaceutical Industries Ltd. (Jerusalem)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Merck Sharp & Dohme Corp. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mylan N.V. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Reckitt Benckiser Group plc. (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Veru Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medisafe Distribution Inc. (Canada)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • CooperSurgical, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Devex (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mayer Laboratories, Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Allergan plc (Ireland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Agile Therapeutics (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • HLL Lifecare (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ANSELL LTD (Australia)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mankind Pharma (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • TTK HealthCare (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Boehringer Ingelheim International GmbH. (Austria)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • V-Care Pharma Pvt. Ltd. (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments